Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 42 results.
User Information
Export Records
  1. 1.   Structural basis of substrate specificity in human cytidine deaminase family APOBEC3s
  2. Hou, Shurong; Lee, Jeong Min; Myint,Wazo; Matsuo,Hiroshi; Yilmaz, Nese Kurt; Schiffer, Celia A.
  3. Journal of Biological Chemistry. 2021, Aug; 297(2):
  1. 2.   Interactions of APOBEC3s with DNA and RNA
  2. Maiti, Atanu; Hou, Shurong; Schiffer, Celia A.; Matsuo,Hiroshi
  3. Current opinion in structural biology. 2021, Apr; 67: 195-204.
  1. 3.   Structural Analysis of the Active Site and DNA Binding of Human Cytidine Deaminase APOBEC3B
  2. Hou, Shurong; Silvas, Tania V.; Leidner, Florian; Nalivaika, Ellen A.; Matsuo,Hiroshi; Yilmaz, Nese Kurt; Schiffer, Celia A.
  3. JOURNAL OF CHEMICAL THEORY AND COMPUTATION. 2019, Jan 8; 15(1): 637-647.
  1. 4.   Structure of a eukaryotic RNase III postcleavage complex reveals a double-ruler mechanism for substrate selection
  2. Liang, Y. H.; Lavoie, M.; Comeau, M. A.; Abou Elela, S.; Ji, X.
  3. Molecular Cell. 2014, 8-May; 54(3): 431-44.
  1. 5.   Molecular Dynamics Approaches Estimate the Binding Energy of HIV-1 Integrase Inhibitors and Correlate with In Vitro Activity
  2. Johnson, B. C.; Metifiot, M.; Pommier, Y.; Hughes, S. H.
  3. Antimicrobial Agents and Chemotherapy. 2012, Jan; 56(1): 411-419.
  1. 6.   Biological evaluation of imidazolium- and ammonium-based salts as HIV-1 integrase inhibitors
  2. Maddali, K.; Kumar, V.; March, C.; Pommier, Y.; Malhotra, S. V.
  3. Medchemcomm. 2011, Feb; 2(2): 143-150.
  1. 7.   Galectin-1 as a fusion partner for the production of soluble and folded human beta-1,4-galactosyltransferase-T7 in E. coil
  2. Pasek, M.; Boeggeman, E.; Ramakrishnan, B.; Qasba, P. K.
  3. Biochemical and Biophysical Research Communications. 2010, Apr; 394(3): 679-684.
  1. 8.   Overproduction, purification and structure determination of human dual-specificity phosphatase 14
  2. Lountos, G. T.; Tropea, J. E.; Cherry, S.; Waugh, D. S.
  3. Acta crystallographica. Section D, Biological crystallography. 2009, Oct; 65(Pt 10): 1013-20.
  1. 9.   An Allosteric Mechanism for Inhibiting HIV-1 Integrase with a Small Molecule
  2. Kessl, J. J.; Eidahl, J. O.; Shkriabai, N.; Zhao, Z. J.; Mckee, C. J.; Hess, S.; Burke, T. R.; Kvaratskhelia, M.
  3. Molecular Pharmacology. 2009 76(4): 824-832.
  1. 10.   Synthesis of conformationally locked carbocyclic nucleoside phosphonates to probe the active site of HIV-1 RT
  2. Saneyoshi, H.; Vu, B. C.; Hughes, S. H.; Boyer, P. L.; Sarafianos, S. G.; Marquez, V. E.
  3. Nucleic acids symposium series (2004). 2008 (52): 623-4.
  1. 11.   Structure-assisted discovery of Variola major H1 phosphatase inhibitors
  2. Phan, J.; Tropea, J. E.; Waugh, D. S.
  3. Acta Crystallographica Section D-Biological Crystallography. 2007, Jun; 63: 698-704.
  1. 12.   Natural products active in aberrant c-Kit signaling
  2. Henrich, C. J.; Goncharova, E. I.; Wilson, J. A.; Gardella, R. S.; Johnson, T. R.; McMahon, J. B.; Takada, K.; Bokesch, H. R.; Gustafson, K. R.
  3. Chemical Biology & Drug Design. 2007, May; 69(5): 321-330.
  1. 13.   Direct identification of nonreducing GlcNAc residues on N-glycans of glycoproteins using a novel chemoenzymatic method
  2. Boeggeman, E.; Ramakrishnan, B.; Kilgore, C.; Khidekel, N.; Hsieh-Wilson, L. C.; Simpson, J. T.; Qasba, P. K.
  3. Bioconjugate Chemistry. 2007, May-Jun; 18(3): 806-814.
  1. 14.   Retroviral DNA integration: reaction pathway and critical intermediates
  2. Li, M.; Mizuuchi, M.; Burke, T. R.; Craigie, R.
  3. Embo Journal. 2006, Mar; 25(6): 1295-1304.
  1. 15.   Cytokinesis regulator ECT2 changes its conformation through phosphorylation at Thr-341 in G2/M phase
  2. Hara, T.; Abe, M.; Inoue, H.; Yu, L. R.; Veenstra, T. D.; Kang, Y. H.; Lee, K. S.; Miki, T.
  3. Oncogene. 2006, JAN; 25(4): 566-578.
  1. 16.   HIV integrase inhibitors with nucleobase scaffolds: Discovery of a highly potent anti-HIV agent
  2. Nair, V.; Chi, G.; Ptak, R.; Neamati, N.
  3. Journal of Medicinal Chemistry. 2006, Jan; 49(2): 445-447.
  1. 17.   Oligosaccharide preferences of beta 1,4-galactosyltransferase-I: Crystal structures of Met340His mutant of human beta 1,4-galactosyltransferase-I with a pentasaccharide and trisaccharides of the N-glycan moiety
  2. Ramasamy, V.; Ramakrishnan, B.; Boeggeman, E.; Ratner, D. M.; Seeberger, P. H.; Qasba, P. K.
  3. Journal of Molecular Biology. 2005, OCT 14; 353(1): 53-67.
  1. 18.   Substrate specificity of the human protein phosphatase 2C delta Wip1
  2. Yamaguchi, H.; Minopoli, G.; Demidov, O. N.; Chatterjee, D. K.; Anderson, C. W.; Durell, S. R.; Appella, E.
  3. Biochemistry. 2005, APR 12; 44(14): 5285-5294.
  1. 19.   Mutation of arginine 228 to lysine enhances the glucosyltransferase activity of bovine beta-1,4-galactosyltransferase I
  2. Ramakrishnan, B.; Boeggeman, E.; Qasba, P. K.
  3. Biochemistry. 2005, MAR 8; 44(9): 3202-3210.
  1. 20.   Mass spectrometric analysis of the HIV-1 integrase-pyridoxal 5 '-phosphate complex reveals a new binding site for a nucleotide inhibitor
  2. Williams, K. L.; Zhang, Y. J.; Shkriabai, N.; Karki, R. G.; Nicklaus, M. C.; Kotrikadze, N.; Hess, S.; Le Grice, S. F. J.; Craigie, R.; Pathak, V. K.; Kvaratskhelia, M.
  3. Journal of Biological Chemistry. 2005, MAR 4; 280(9): 7949-7955.
  1. 21.   PKC delta plays opposite roles in growth mediated by wild-type Kit and an oncogenic Kit mutant
  2. Jelacic, T.; Linnekin, D.
  3. Blood. 2005, MAR 1; 105(5): 1923-1929.
  1. 22.   Integrase of Mason-Pfizer monkey virus
  2. Snasel, J.; Krejcik, Z.; Jencova, V.; Rosenberg, I.; Ruml, T.; Alexandratos, J.; Gustchina, A.; Pichova, I.
  3. Febs Journal. 2005, JAN; 272(1): 203-216.
  1. 23.   Model of full-length HIV-1 integrase complexed with viral DNA as template for anti-HIV drug design
  2. Karki, R. G.; Tang, Y.; Burke, T. R.; Nicklaus, M. C.
  3. Journal of Computer-Aided Molecular Design. 2004, DEC; 18(12): 739-760.
  1. 24.   Stem sequence at the N-terminal region of B-1,4-galactosyltransferase T5 and T6 increases the folding efficiencies of their respective catalytic domains by step-wise or single step folding method
  2. Dubey, H.; Ramakrishnan, B.; Boeggeman, E.; Qasba, P. K.
  3. Glycobiology. 2004, NOV; 14(11): 1192, Abstract 492-1192, Abstract 492.
  1. 25.   Design and synthesis of novel indole beta-diketo acid derivatives as HIV-1 integrase inhibitors
  2. Sechi, M.; Derudas, M.; Dallocchio, R.; Dessi, A.; Bacchi, A.; Sannia, L.; Carta, F.; Palomba, M.; Ragab, O.; Chan, C.; Shoemaker, R.; Sei, S.; Dayam, R.; Neamati, N.
  3. Journal of Medicinal Chemistry. 2004, OCT 7; 47(21): 5298-5310.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel